129 related articles for article (PubMed ID: 35899496)
1. Errate: Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
Yang Z; Cheng H; Zhang Y; Zhou Y
Med Sci Monit; 2022 Jul; 28():e937786. PubMed ID: 35899496
[TBL] [Abstract][Full Text] [Related]
2. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
Yang Z; Cheng H; Zhang Y; Zhou Y
Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
[TBL] [Abstract][Full Text] [Related]
4. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
6. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
[TBL] [Abstract][Full Text] [Related]
10. CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase.
Gao F; Li C; Zhao X; Xie J; Fang G; Li Y
J Oral Pathol Med; 2021 Feb; 50(2):175-182. PubMed ID: 33107644
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
Lan Y; Zhang Y; Wang J; Lin C; Ittmann MM; Wang F
Int J Cancer; 2008 Aug; 123(3):543-51. PubMed ID: 18498131
[TBL] [Abstract][Full Text] [Related]
12. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.
Mo C; Wu Y; Ma J; Xie L; Huang Y; Xu Y; Peng H; Chen Z; Zeng M; Mao R
BMC Med Genomics; 2022 Apr; 15(1):81. PubMed ID: 35410253
[TBL] [Abstract][Full Text] [Related]
14. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
[TBL] [Abstract][Full Text] [Related]
16. Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
Subramanian C; Cohen MS
Surgery; 2019 Jan; 165(1):202-210. PubMed ID: 30413320
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.
Feng J; Hu M; Li Z; Hu G; Han Y; Zhang Y; Zhang M; Ren J
Cells; 2022 Aug; 11(16):. PubMed ID: 36010686
[TBL] [Abstract][Full Text] [Related]
18. CKS2 Promotes the Growth in Non-Small-Cell Lung Cancer by Downregulating Cyclin-Dependent Kinase Inhibitor.
Wan Z; Wang L; Yang D; Li P; Liu Q; Wang B
Pathobiology; 2022; 89(1):13-22. PubMed ID: 34333494
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart.
Zhou RH; Kokame K; Tsukamoto Y; Yutani C; Kato H; Miyata T
Genomics; 2001 Apr; 73(1):86-97. PubMed ID: 11352569
[TBL] [Abstract][Full Text] [Related]
20. Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods.
Gao L; Chen G; Liang ZQ; Li JD; Li DM; Tang YL; Tang D; Huang ZG; Chen JH; Luo JY; Zeng JH; Dang YW; Feng ZB
Pathol Oncol Res; 2022; 28():1610307. PubMed ID: 35693634
[No Abstract] [Full Text] [Related]
[Next] [New Search]